At DrugMode we believe that understanding how a disease is caused at the molecular level - by interacting pathways of proteins or single proteins (proteomic fingerprint) in the human organism - is fundamental to highly efficient and successful drug discovery and development.

We have demonstrated in our system that the proteomic fingerprint of a disease found in animal studies corresponds poorly to the proteomic fingerprint of the same disease in humans. This is why many potentially new drugs developed on basis of animal studies fail in practice both in terms of efficacy and safety.

DrugMode provides proprietary human in vitro systems to generate uniquely relevant human data for pre-clinical development of drugs and diagnostic tools. This significantly increases the success rate and reduces time to market and cost of development.

We use our expertise within:

1. Drug Target Identification
2. Drug Testing
3. Toxicology
4. Early Diagnostic Markers